Evidence map›Paper›PMID 41601605›Full record

ArticleFrontiers in human neuroscience2025

Hybrid deep learning and feature optimization approach for early detection of multiple sclerosis.

Nandini Anam, Sharief Basha S, Chiranji Lal Chowdhary

Abstract read
In one paragraph

Article in Frontiers in human neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nandini AnamDepartment of Mathematics, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Sharief Basha SDepartment of Analytics, School of Computer Science and Engineering, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Chiranji Lal ChowdharyDepartment of Software and Systems Engineering, School of Computer Science Engineering and Information System, Vellore Institute of Technology, Vellore, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The healthcare field increasingly relies on autonomous systems for the detection and analysis of Multiple Sclerosis (MS) to minimize diagnostic delays, resource burdens, reduce the progression of disability, and enhance clinical decision-making efficiency. Such systems ensure accurate and timely treatment, ultimately improved patient outcomes. In this study, a hybrid framework combining deep learning-based feature extraction, metaheuristic feature selection, and machine learning (ML) classifiers is proposed for accurate MS classification. All MRI images were preprocessed using Contrast Limited Adaptive Histogram Equalization (CLAHE), resizing, and normalization to enhance contrast and standardize the input dimensions. Deep features were extracted using the pretrained VGG16 convolutional neural network (CNN), in which the fully connected layers were removed, and the convolutional base was used to obtain high-dimensional features per image. To reduce dimensionality and improve classification performance, the Whale Optimization Algorithm (WOA) was employed to select the most discriminative subset of features using a Support Vector Machine (SVM)-based fitness function. Multiple classifiers were then trained and evaluated using the optimized feature set. Among them, the Artificial Neural Network integrated with WOA (ANN+WOA) achieved the highest classification accuracy of 98%, demonstrating the potential of the proposed model for reliable, efficient, and automated MS diagnosis.

Indexed as

CNNfeature extractionMRImultiple sclerosiswhale optimization algorithm (WOA)

Identifiers

PMID41601605
PMCPMC12833296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.